These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9382011)
1. Association of fasting plasma free fatty acid concentration and frequency of ventricular premature complexes in nonischemic non-insulin-dependent diabetic patients. Paolisso G; Gualdiero P; Manzella D; Rizzo MR; Tagliamonte MR; Gambardella A; Verza M; Gentile S; Varricchio M; D'Onofrio F Am J Cardiol; 1997 Oct; 80(7):932-7. PubMed ID: 9382011 [TBL] [Abstract][Full Text] [Related]
2. Hyperinsulinemia is associated with ventricular premature complexes. Paolisso G; Gualdiero P; Manzella D; Gambardella A; Verza M; Gentile S; Varricchio M Metabolism; 1996 Oct; 45(10):1248-53. PubMed ID: 8843180 [TBL] [Abstract][Full Text] [Related]
3. Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. Manzella D; Barbieri M; Rizzo MR; Ragno E; Passariello N; Gambardella A; Marfella R; Giugliano D; Paolisso G J Clin Endocrinol Metab; 2001 Jun; 86(6):2769-74. PubMed ID: 11397885 [TBL] [Abstract][Full Text] [Related]
4. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. Bajaj M; Suraamornkul S; Kashyap S; Cusi K; Mandarino L; DeFronzo RA J Clin Endocrinol Metab; 2004 Sep; 89(9):4649-55. PubMed ID: 15356076 [TBL] [Abstract][Full Text] [Related]
5. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438 [TBL] [Abstract][Full Text] [Related]
6. Effects of Acipimox on the metabolism of free fatty acids and very low lipoprotein triglyceride. Hannah JS; Bodkin NL; Paidi MS; Anh-Le N; Howard BV; Hansen BC Acta Diabetol; 1995 Dec; 32(4):279-83. PubMed ID: 8750769 [TBL] [Abstract][Full Text] [Related]
7. The nicotinic acid analogue acipimox increases plasma leptin and decreases free fatty acids in type 2 diabetic patients. Worm D; Vinten J; Vaag A; Henriksen JE; Beck-Nielsen H Eur J Endocrinol; 2000 Sep; 143(3):389-95. PubMed ID: 11022182 [TBL] [Abstract][Full Text] [Related]
8. Meformin, plasma glucose and free fatty acids in type II diabetic out-patients: results of a clinical study. Gregorio F; Ambrosi F; Manfrini S; Santucci A; Filipponi P Diabetes Res Clin Pract; 1997 Jul; 37(1):21-33. PubMed ID: 9279474 [TBL] [Abstract][Full Text] [Related]
9. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. Cusi K; Kashyap S; Gastaldelli A; Bajaj M; Cersosimo E Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1775-81. PubMed ID: 17299078 [TBL] [Abstract][Full Text] [Related]
10. Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals. Daniele G; Eldor R; Merovci A; Clarke GD; Xiong J; Tripathy D; Taranova A; Abdul-Ghani M; DeFronzo RA Diabetes; 2014 Aug; 63(8):2812-20. PubMed ID: 24353180 [TBL] [Abstract][Full Text] [Related]
11. Fasting serum free fatty acid composition, waist/hip ratio and insulin activity in essential hypertensive patients. Wang S; Ma A; Song S; Quan Q; Zhao X; Zheng X Hypertens Res; 2008 Apr; 31(4):623-32. PubMed ID: 18633173 [TBL] [Abstract][Full Text] [Related]
12. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes. Paolisso G; Tagliamonte MR; Rizzo MR; Gualdiero P; Saccomanno F; Gambardella A; Giugliano D; D'Onofrio F; Howard BV Diabetologia; 1998 Oct; 41(10):1127-32. PubMed ID: 9794097 [TBL] [Abstract][Full Text] [Related]
13. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. Boden G; Chen X Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559 [TBL] [Abstract][Full Text] [Related]
14. Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects. Liang H; Tantiwong P; Sriwijitkamol A; Shanmugasundaram K; Mohan S; Espinoza S; Defronzo RA; Dubé JJ; Musi N J Physiol; 2013 Jun; 591(11):2897-909. PubMed ID: 23529132 [TBL] [Abstract][Full Text] [Related]
15. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids. Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850 [TBL] [Abstract][Full Text] [Related]
16. Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? Paolisso G; Gambardella A; Tagliamonte MR; Saccomanno F; Salvatore T; Gualdiero P; D'Onofrio MV; Howard BV J Clin Endocrinol Metab; 1996 Dec; 81(12):4244-8. PubMed ID: 8954022 [TBL] [Abstract][Full Text] [Related]
18. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. Lewis GF; Uffelman KD; Szeto LW; Weller B; Steiner G J Clin Invest; 1995 Jan; 95(1):158-66. PubMed ID: 7814610 [TBL] [Abstract][Full Text] [Related]
19. [Fasting serum free fatty acid, insulin sensitivity index and serum lipid levels in individuals with different body mass index and glucose tolerance]. Zhang YF; Hong J; Gu WQ; Sun SY; Tang JF; Jiang L; Dai M; Zhao YJ; Ning G Zhonghua Nei Ke Za Zhi; 2003 Nov; 42(11):793-6. PubMed ID: 14636469 [TBL] [Abstract][Full Text] [Related]
20. Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels. Lehto HR; Pärkkä J; Borra R; Tuunanen H; Lepomaki V; Parkkola R; Knuuti J; Nuutila P; Iozzo P J Clin Endocrinol Metab; 2012 Sep; 97(9):3277-84. PubMed ID: 22761459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]